Having trouble accessing articles? Reset your cache.

PF-00299804: Phase II data

An international Phase II trial in 188 patients who had failed 1 or 2 prior chemotherapy regimens showed that 45 mg once-daily PF-00299804 met the primary

Read the full 260 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE